Home/Filings/4/0001055726-25-000042
4//SEC Filing

Shea Jacqueline Elizabeth 4

Accession 0001055726-25-000042

CIK 0001055726other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 4:58 PM ET

Size

8.2 KB

Accession

0001055726-25-000042

Insider Transaction Report

Form 4
Period: 2025-05-20
Shea Jacqueline Elizabeth
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock Option

    2025-05-20+105,262105,262 total
    Exercise: $2.13Exp: 2035-05-20Common Stock (105,262 underlying)
  • Award

    Restricted Stock Unit

    2025-05-20+84,88884,888 total
    Common Stock (84,888 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
  • [F2]The vesting schedule for the 105,262 options is as follows: 52,631 shares will vest on May 20, 2027 and 52,631 shares will vest on May 20, 2028.

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001771498

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:58 PM ET
Size
8.2 KB